NCT03229993View on ClinicalTrials.gov

OCT in Borderline Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

December 31, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

December 31, 2019

Conditions
Optical Coherence Tomography (OCT)Percutaneous Coronary Intervention (PCI)Single-Photon Emission Computed Tomography (SPECT)Coronary Angiography (CAG)Borderline Coronary Artery Lesions
Interventions
DIAGNOSTIC_TEST

OCT

OCT is used to assess whether PCI will be of benefit to the treatment of the borderline coronary artery lesions

Trial Locations (1)

210029

First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT03229993 - OCT in Borderline Coronary Artery Lesions | Biotech Hunter | Biotech Hunter